Now showing items 1-2 of 2

    • Joll II, Jeffery Ethan; 0000-0001-7941-6380 (2022-03-15)
      Department: Biomedical Engineering
      In 2017 the sclerostin targeting monoclonal antibody Romosozumab was approved as a treatment for post-menopausal osteoporosis (PMO) despite cardiovascular side effects discovered in clinical trials. Previous studies indicated ...
    • DeBoer, Jennifer Jean (2012-04-30)
      Department: Leadership and Policy Studies
      In this dissertation, I examine the mechanisms that create qualified engineers. I am motivated by the important role that engineers play in the economic and social development of nations around the world. First, I ask ...